PETER BURNS: Open Payments
NPI 1891727533 · LOGANSPORT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,672 in 36 payments from 10 companies in 2025. Trend: 2023 $965 · 2024 $1,456 · 2025 $1,672
Food & beverage: $1,561Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $616 |
| E.R. Squibb & Sons, L.L.C. | 5 | $200 |
| ABBVIE INC. | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| Alkermes, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 1 | $119 |
| Janssen Pharmaceuticals, Inc | 2 | $119 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Lundbeck LLC | 4 | $92 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
Products named: REXULTI, COBENFY, ABILIFY MAINTENA, VRAYLAR, Leqembi, LYBALVI, INGREZZA, INVEGA SUSTENNA.
Industry payments across IN — which companies pay providers there.
